Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
SLNO
#1669
Soleno Therapeutics, Inc. Common Stock
39.0
7
+5.51%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
+5.51%
Monthly Change
-9.20%
6 month change
-42.34%
Cambio anual
-13.27%
Cierres anteriores
37.0
3
Open
39.0
7
Bid
Ask
Low
39.0
7
High
39.0
7
Volumen
143
Markets
Acciones
Atención Sanitaria
SLNO
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
43.12 M
45.86 M
50.39 M
53.15 M
53.71 M
51.62 M
—
Valuation ratios
Enterprise value
2.13 B
1.97 B
3.52 B
4.38 B
3.38 B
2.32 B
13.6 B
Price to earnings ratio
-18.63
-10.26
-15.07
-19.67
-34.49
118.72
49.49
Price to sales ratio
—
—
—
—
—
—
—
Price to cash flow ratio
-31.87
-26.14
-33.05
-42.95
-96.78
51.83
-120.95
Price to book ratio
1.82
7.37
2.81
3.66
2.6
5.39
14.46
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.26
0.17
0.14
0.01
0.04
-0.1
0.1
Return on equity %
0.29
0.23
0.19
0.02
0.05
-0.12
0.14
Return on invested capital %
—
116.71
—
—
—
-32.78
—
Gross margin %
—
—
—
97.87
98.27
—
—
Operating margin %
—
—
—
19.98
33.48
—
—
EBITDA margin %
—
—
—
-25.07
31.21
—
—
Net margin %
—
—
—
14.42
39.4
—
—
Liquidity ratios
Quick ratio
—
—
—
15.01
15.88
5.55
—
Current ratio
17.26
15.68
19.64
15.13
16.08
5.8
56.65
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
—
—
—
0.1
0.14
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
0.15
0.16
0.15
0.08
0.09
—
Long term debt to total equity ratio
—
0.2
0.21
0.21
0.1
0.11
—
Per share metrics
Operating cash flow per share
0.36
0.6
0.71
0.25
-0.79
0.86
1.02
EBIT per share
—
—
—
-0.14
0.38
—
—
EBITDA per share
—
—
—
-0.16
0.38
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
6.13
2.19
6.28
5.68
9.09
5.83
26.88
Net current asset value per share
6.17
7.32
6.69
6.28
9.74
6.79
29.5
Tangible book value per share
6.15
5.93
4.89
4.64
8.91
8.5
26.95
Working capital per share
5.81
6.85
6.35
5.86
9.13
5.62
26.96
Book value per share
6.32
6.1
5.03
4.76
9.01
8.59
27.39
Noticias
Las acciones de Soleno Therapeutics alcanzan mínimos de 52 semanas en 36,01 dólares
Soleno Therapeutics stock hits 52-week low at 36.01 USD
Soleno Therapeutics nombra a Jennifer Fulk como directora financiera
Soleno Therapeutics names Jennifer Fulk as CFO
Soleno Therapeutics earnings beat by $0.19, revenue topped estimates
Soleno Therapeutics enfrenta prueba de resultados mientras se examinan métricas de lanzamiento
Soleno Therapeutics faces earnings test as launch metrics scrutinized
Las acciones de Soleno Therapeutics caen a mínimos de 52 semanas a 37,95 dólares
Soleno Therapeutics stock hits 52-week low at 37.95 USD
Ultragenyx Pharmaceutical Resubmits UX111 BLA for Sanfilippo Syndrome
Down 18.3% in 4 Weeks, Here's Why Soleno Therapeutics (SLNO) Looks Ripe for a Turnaround
FDA Accepts SMMT's Application Seeking Approval for NSCLC Drug